Veracyte Inc VCYT:NASDAQ

Last Price$29.85NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/19/19

Today's Change+0.34(1.15%)
Bid (Size)$29.87 (1)
Ask (Size)$29.89 (55)
Day Low / High$29.45 - 29.93
Volume415.4 K
  • Latest Stories
  • Commentary and Analysis
Analyst Actions: Needham Starts Veracyte at Buy, Price Target is $33
9:09AM ET 7/02/2019 MT Newswires

Veracyte (VCYT) has an average rating among analysts of buy, with an average price target of $18 Price: 28.75, Change: +0.24, Percent Change: +0.84 ...

Veracyte COO To Retire
4:09AM ET 7/01/2019 MT Newswires

Veracyte (VCYT) said in a Friday regulatory filing that Christopher Hall intends to retire as COO, effective July 1. Keith Kennedy, the company's current...

Veracyte Says Cancer Cytopathology Details Co.'s Role in Reducing 'Unnecessary' Surgeries in Thyroid Cancer Diagnosis
2:56PM ET 6/17/2019 MT Newswires

Veracyte (VCYT) said Monday a review article in Cancer Cytopathology, a journal of the American Cancer Society, describes how the technology behind...

Veracyte Seeks $136 Mln From Share Sale at 3.8% Discount for Potential Acquisitions, Debt Payment
8:46AM ET 5/03/2019 MT Newswires

Veracyte Inc. (VCYT) late Thursday said it plans to raise $127.9 million selling 5.5 million shares at $23.25 apiece, or 3.8% below Thursday's close....

Veracyte Prices 5.5 Mln Shares at $23.25 Each in Offering
8:59PM ET 5/02/2019 MT Newswires

Veracyte (VCYT) said it priced 5.5 million shares at $23.25 each in an underwritten public offering. The offering is expected to close on or about May 7....

Veracyte Plans to Sell 5 Mln Shares in Underwritten Public Offering
5:14PM ET 5/01/2019 MT Newswires

Veracyte (VCYT) said it plans to sell 5 million shares in an underwritten public offering and expects to grant the underwriters a 30-day option to purchase...

MTNewswires After-Hours News Movers
5:52PM ET 4/30/2019 MT Newswires

Some of the stocks moving on news-driven events in Tuesday's after-hours include: STAF, +16.36% ARLO, +12.34% NUS, +10.58% TNDM, +7.64% AAPL, +4.65% VCYT,...

Veracyte Rises More Than 4% After Q1 Beats Estimates; FY Sales Outlook Boosted Above Street View
5:32PM ET 4/30/2019 MT Newswires

Veracyte (VCYT) gained more than 4% after the company said Q1 sales rose 47% to $29.5 million from the year-ago period and topped the CapIQ mean for $27.59...

Veracyte Shares Positive Data That Its Envisia Genomic Classifier Improves Diagnosis of Interstitial Lung Diseases
9:57AM ET 4/02/2019 MT Newswires

Veracyte (VCYT) said late Monday that data published online in The Lancet Respiratory Medicine suggest that use of the company's Envisia Genomic Classifier...

Significant Insider Sales Reported in Shares of Veracyte (VCYT)
10:09PM ET 3/05/2019 MT Newswires

There was a notable level of share sales at Veracyte today, as disclosed in filings with the SEC. Two insiders -- Jesse I Treu, Director, and Evan Jones,...